W 140 (Lansoprazole delayed release 15 mg)

Pill imprint W 140 has been identified as Lansoprazole delayed release 15 mg.

Lansoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; zollinger-ellison syndrome; duodenal ulcer (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for W 140

Lansoprazole delayed release 15 mg W 140
Lansoprazole delayed release
Imprint:
W 140
Strength:
15 mg
Color:
Pink / Green
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Wockhardt Limited
National Drug Code (NDC):
55648-0140
Inactive Ingredients:
D&C Red No. 33
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Red No. 40
gelatin
hypromelloses
magnesium carbonate
polyethylene glycol
polysorbate 80
silicon dioxide
corn starch
sucrose
magnesium silicate
titanium dioxide
methacrylic acid - methyl methacrylate copolymer (1:1)

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)